|
|
|
Volumn 23, Issue 3 SUPPL. 7, 1996, Pages 34-39
|
|
High-dose ifosfamide in the treatment of advanced soft tissue sarcomas
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DACARBAZINE;
DOCETAXEL;
DOXORUBICIN;
IFOSFAMIDE;
OXAZAPHOSPHORINE DERIVATIVE;
ADULT;
AGED;
ARTICLE;
BONE MARROW TOXICITY;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTINUOUS INFUSION;
DRUG MEGADOSE;
FEMALE;
HEMORRHAGIC CYSTITIS;
HUMAN;
MALE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
PRIORITY JOURNAL;
SOFT TISSUE SARCOMA;
TREATMENT OUTCOME;
ADULT;
AGED;
ANTINEOPLASTIC AGENTS, ALKYLATING;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
HUMANS;
IFOSFAMIDE;
MALE;
MIDDLE AGED;
SARCOMA;
SOFT TISSUE NEOPLASMS;
|
|
EID: 0029776739
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (17)
|
|
References (0)
|
